UCB SA (UCBJF)
236.94
+1.50
(+0.64%)
USD |
OTCM |
Oct 06, 16:00
UCB Market Cap : 45.18B for Oct. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 06, 2026 | 45.18B |
| October 05, 2026 | 44.89B |
| October 02, 2026 | 45.48B |
| October 01, 2026 | 44.51B |
| September 30, 2026 | 47.03B |
| September 29, 2026 | 47.03B |
| September 28, 2026 | 46.92B |
| September 25, 2026 | 44.93B |
| September 24, 2026 | 46.50B |
| September 23, 2026 | 45.09B |
| September 22, 2026 | 45.09B |
| September 21, 2026 | 44.59B |
| September 18, 2026 | 47.76B |
| September 17, 2026 | 47.12B |
| September 16, 2026 | 47.31B |
| September 15, 2026 | 47.78B |
| September 14, 2026 | 48.06B |
| September 11, 2026 | 46.93B |
| September 10, 2026 | 44.19B |
| September 09, 2026 | 46.99B |
| September 08, 2026 | 47.92B |
| September 04, 2026 | 48.68B |
| September 03, 2026 | 47.40B |
| September 02, 2026 | 50.35B |
| September 01, 2026 | 48.08B |
| Date | Value |
|---|---|
| August 31, 2026 | 47.83B |
| August 28, 2026 | 47.83B |
| August 27, 2026 | 51.02B |
| August 26, 2026 | 50.83B |
| August 25, 2026 | 50.97B |
| August 24, 2026 | 50.97B |
| August 21, 2026 | 50.16B |
| August 20, 2026 | 49.40B |
| August 19, 2026 | 49.83B |
| August 18, 2026 | 48.54B |
| August 17, 2026 | 48.54B |
| August 14, 2026 | 48.54B |
| August 13, 2026 | 50.16B |
| August 12, 2026 | 49.83B |
| August 11, 2026 | 50.41B |
| August 10, 2026 | 50.73B |
| August 07, 2026 | 51.35B |
| August 06, 2026 | 51.45B |
| August 05, 2026 | 51.45B |
| August 04, 2026 | 49.28B |
| August 03, 2026 | 50.30B |
| July 31, 2026 | 51.41B |
| July 30, 2026 | 49.49B |
| July 29, 2026 | 56.36B |
| July 28, 2026 | 53.48B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 622.21B |
| Eli Lilly & Co. | 1.119T |
| Novo Nordisk A/S | 128.01B |
| Pfizer Inc. | 159.49B |
| Teva Pharmaceutical Industries Ltd. | 45.62B |
Market Cap Related Metrics
| PE Ratio | 17.97 |
| PS Ratio | 4.625 |
| PEG Ratio | 0.0201 |
| Price to Free Cash Flow | 32.67 |
| Price | 236.94 |
| Earnings Yield | 5.57% |
| PEGY Ratio | 0.0201 |
| Operating PE Ratio | 14.53 |
| Normalized PE Ratio | 17.81 |